FWT and OBT concentrations in pine needle samples collected at Toki, Japan (1998-2012).

Free water tritium (FWT) and organically bound tritium (OBT) concentrations in pine needles have been investigated to understand the regional background tritium concentration in Toki City. Samples were regularly collected from pine trees on the National Institute for Fusion Science campus (1998-2012) and the nearby Shiomi Park (SP; 2002-12). FWT and OBT concentrations of the former samples ranged from 0.33 to 0.92 and 0.41 to 1.10 Bq l(-1), respectively, while those of the latter samples ranged from 0.32 to 0.86 and 0.33 to 0.79 Bq l(-1), respectively. Results of both sampling sites were almost the same, and they have been gradually decreased year by year. Concentration level of tritium for Toki City was close to the average background level in Japan. The OBT/FWT ratios were almost 1.0. The apparent half-life of FWT in this period was estimated as almost 10 y, and that of OBT was estimated as almost 12 y; these values were almost the same as the physical half-life.

The biological activity and immunotherapeutic properties of AS-101, a synthetic organotellurium compound.

AS-101 (ammonium trichloro[dioxoethylene-O,O'-]tellurate) is a newly developed synthetic compound with immunomodulating properties and minimal toxicity. We evaluated the effects of AS-101 on various parameters of the activation and function of immunocompetent cells. AS-101 induced IL-2 receptor expression, IL-2 production and proliferation by human and mouse lymphocytes in vitro and enhanced the production colony-stimulating factor (CSF) by mouse spleen cells. In vivo treatment of Balb/c mice with AS-101 caused a significantly increased production of IL-2 and CSF in vitro in the presence of mitogen. When administered systemically to mice, AS-101 mediated antitumor effects in vivo. These results suggest that AS-101 is an active biological response modifier, which might have potential use in the treatment of conditions such as malignancy, AIDS and some types of immune deficiency.

A new immunomodulating compound (AS-101) with potential therapeutic application.

There has been interest in the potential of synthetic compounds to modify immune responses by imitation of cytokine action. Direct administration of interleukin 2 (IL-2) in conjunction with adoptive transfer of lymphokine activated killer cells has been used in the treatment of cancer, but there are toxic effects resulting from the high doses of IL-2 required. We have developed a new synthetic compound, ammonium tri-chloro(dioxoethylene-O,O'-)tellurate (AS-101), which has immunomodulating properties and minimal toxicity. The effects of AS-101 on the activation and function of immunocompetent cells have been assessed. We have found that AS-101 induces proliferation and IL-2 production by human lymphocytes in vitro, and enhances the production of IL-2 and colony-stimulating factor by mouse spleen cells. Splenocytes of BALB/c mice injected with AS-101 increased production of IL-2 and CSF in vitro in the presence of mitogen. Mononuclear cells of normal donors acquired responsiveness to recombinant IL-2 and bound monoclonal antibody to IL-2 receptor after incubation with AS-101. Splenocytes of mice treated in vivo with AS-101 expressed high levels of IL-2 receptor. The stimulation of lymphocytes by AS-101 apparently involves an increase in intracellular free calcium. AS-101 administered systemically to mice mediated antitumour effects which could be attributable to its immunomodulatory properties. In addition, AS-101 could directly enhance the ratio of OKT4 to OKT8-positive cells in cultured mononuclear cells from AIDS (acquired immune deficiency syndrome) patients. These results indicate that AS-101 is potentially useful in the treatment of clinical conditions involving immunosuppression.